Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...